Philadelphia, Pennsylvania 19104


The goal of this pilot project is to assess adherence with home blood pressure monitoring in hypertensive patients with a history of cerebral infarction and to determine if a social incentive improves adherence with monitoring. Enrolled subjects will all have a history of cerebral infarction and uncontrolled blood pressure, defined by SBP>140 or DBP>90 mm Hg at the time of enrollment. To be eligible subjects will also be required to own a smart phone (iOS or Android operating system). After enrollment, patients will be given a home blood pressure cuff with instructions to monitor their BP twice daily for 90 days. Subjects will be randomly assigned to a social incentive program, in which a social supporter receives updates via email and/or text message on the subject's adherence with BP monitoring and their average blood pressure. This study will provide important pilot data which will inform the design of future studies utilizing connected health and automated systems to improve home blood pressure monitoring and blood pressure control in patients with a history of stroke.


Inclusion Criteria: - Adult, age ≥ 18 years - History of ischemic stroke or high risk TIA (defined by ABCD2 ≥ 4)between 2 weeks and 12 months prior to enrollment - Hypertensive at time of enrollment, defined by SBP>140 mm Hg or DBP >90 mm Hg at the time of study screening - Must own a smart phone capable of interacting with the connected blood pressure cuff (Apple iPhone 3GS or higher; Android 4.0 or higher with Bluetooth connectivity) - Willingness and ability to sign informed consent by patient Exclusion Criteria: - Moderate or severe disability, defined by modified Rankin Scale ≥ 3. - Expected residence in a rehabilitation hospital, nursing facility or assisted living community during the study period. - Upper arm circumference <9 inches or >17 inches - Inability to monitor BP in both of the upper arms (i.e. history of bilateral radical mastectomy, bilateral severe subclavian stenosis, or bilateral arterial venous fistulas for dialysis). - Blood pressure discrepancy between arms of >10 mm Hg. - Inability to follow-up at 90 days and return BP monitor - Active participation in another clinical trial - Pregnant women



Primary Contact:

Principal Investigator
Michael Mullen, M.D
University of Pennsylvania

Nichole Gallatti, M.S.Ed
Phone: 215-349-8651

Backup Contact:


Location Contact:

Philadelphia, Pennsylvania 19104
United States

Nichole Gallatti
Phone: 215-349-8651

Site Status: Recruiting

Data Source:

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.